Press release
Targeted Delivery Drugs Market 2020 Analysis and Forecast to 2026: Adverum, Arrowhead Pharmaceuticals, Inc., Bayer AG, BioZone Labs, Inc., Windtree Therapeutics, Inc
Targeted Delivery Drugs Market
Global Targeted Delivery Drugs Market By Technology (Nanoparticles, Polymers, Monoclonal antibodies, Gold Nanoparticles-Based Drug Delivery and Imaging, Drug Eluting Stents), Therapeutic Area (Pulmonary, Ocular Drug Delivery, Ocular Nano-Based Drug Delivery Implants, Drug Eluting Stents), Geography (North America, Europe, Asia-Pacific, South America, Middle East And Africa) - Industry Trends & Forecast to 2026
Get Sample Copy of Global Targeted Delivery Drugs Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-targeted-delivery-drugs-market
Market Analysis:
Global targeted delivery drugs market is expected to rise by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in the market can be attributed to the increase in technology advancement and mergers of major players, rise in use of nanotechnology to target specific location and increase in research and development to enhance product portfolio
Market Definition:
Targeted delivery drug is defined as a method to inject drugs inside the body such that it targets only a specific part of body. The goal of targeted delivery drug is to localize, prolong and protect interaction with diseased tissue. Targeted delivery drugs have various advantages such as reduction of any side effects, minimum fluctuation in drug level and treats specific part. The market of targeted delivery drug is rising due to advanced technologies and innovations in the field of healthcare
Market Drivers
Increase in technological advancement and mergers of major players may act as a catalyst for the market growth
Rise in use of nanotechnology to target specific location would enhance the market growth
Increase in research and development to enhance product portfolio can boost the market growth
High throughput and reduce waiting time for improved result has driven the market growth
Market Restraints
Involvement of high cost for treatment can restraint the market growth
Rise in drug re-calls may hamper the growth of the market
Segmentation: Global Targeted Delivery Drugs Market
By Technology
Nanoparticles
Polymers
Micelles
Dendrimers
Monoclonal Antibodies
Gold Nanoparticles-Based Drug Delivery and Imaging
Drug Eluting Stents
By Therapeutic Area
Pulmonary
Inhalers
Dry Powder Inhalers
Nebulizers
Ocular Drug Delivery
Ocular Nano-Based Drug Delivery Implants
Liposomes
Polymers
Drug Eluting Stents
By Geography
North America
South America
Europe
Asia-Pacific
Middle East and Africa
Enquire for customization in Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-targeted-delivery-drugs-market
Key Developments in the Market:
In July 2018, Sensile had been acquired by the Gerresheimer in order to develop the smart devices and drug delivery systems which included products such as inhalers and insulin pens. With the acquisition, Gerresheimer is looking forward to develop a new delivery system which would have digital and electronic capabilities
In September 2017, DeviceVue, an asset for tracking of sigma spectrum infusion system, was launched by the Baxter International Inc. With the launch of new device, Baxter International Inc. entered into the market of smart infusion pump. The new product would Baxter in expansion of their product portfolio in healthcare
Competitive Analysis:
Global targeted delivery drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of targeted delivery drugs market for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Key Market Competitors:
Few of the major market competitors currently working in the global targeted delivery drugs market are Adverum, Arrowhead Pharmaceuticals, Inc., Bayer AG, BioZone Labs, Inc., Windtree Therapeutics, Inc., FIT Biotech Oy, Immunocore, Keystone Nano, Inc., Lipocine Inc., Mankind Pharma, MultiVir, PharmaIN, Corp., F. Hoffmann-La Roche Ltd, Polyactiva Pty Ltd, Spark Therapeutics, Inc., Transgene, Ra Pharmaceuticals, Inc., Vical Inc, Nektar Technology, Inc. and others
Reasons to Purchase this Report
Current and future of global targeted delivery drugs market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Table of Contents:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports
Download Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-targeted-delivery-drugs-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Targeted Delivery Drugs Market 2020 Analysis and Forecast to 2026: Adverum, Arrowhead Pharmaceuticals, Inc., Bayer AG, BioZone Labs, Inc., Windtree Therapeutics, Inc here
News-ID: 1932481 • Views: …
More Releases from Data Bridge Market Research
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size
The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness.
Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the…
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size
Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation…
Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size
The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent…
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
